Measurement of disease activity in systemic lupus erythematosus (SLE) using microarray gene expression analysis.

被引：0
|
作者：
Nikpour, M
Dempsey, A
Urowitz, V
Gladman, D
Barnes, D
机构：
[1] Univ Toronto, Toronto Western Hosp, Lupus Clin, Toronto, ON, Canada
[2] MetriGenix Corp, Toronto, ON, Canada
[3] MetriGenix Corp US Inc, Baltimore, MD USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4055 / 4055
页数：1
相关论文
共 50 条
  • [21] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Reuven Mader
    Samer Mishail
    Muhammed Adawi
    Idit Lavi
    Rafael Luboshitzky
    Clinical Rheumatology, 2007, 26 : 1891 - 1894
  • [22] Association between Changes in Gene Signature Expression and Disease Activity in Systemic Lupus Erythematosus
    Petri, Michelle
    Fu, Wei
    Ranger, Ann
    Allaire, Normand
    Cullen, Patrick
    Magder, Laurence S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Implementation of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) Documentation in Systemic Lupus Erythematosus (SLE) Patients at an Academic Medical Center
    Chung, Sarah H.
    Juo, Hsin-Hsuan
    Thomason, Jenna
    Bays, Alison
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] Disease Activity Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Morand, Eric
    Furie, Richard
    Peschken, Christine
    Aringer, Martin
    Arnaud, Laurent
    Desta, Barnabas
    Een, Tina Grunfeld
    Sorrentino, Alessandro
    Chen, Stephanie
    Ding, Bo
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4484 - 4486
  • [25] Atherosclerosis In Systemic Lupus Erythematosus (SLE) and Controls, -An Analysis Of SLE Subgroups
    Gustafsson, Johanna
    Jensen-Urstad, Kerstin
    Herlitz-Lindberg, Marie
    Moller, Sonia
    Pettersson, Susanne
    Gunnarsson, Iva
    Larsson, Anders
    Svenungsson, Elisabet
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1243 - S1243
  • [26] Atherosclerosis in systemic lupus erythematosus (SLE) and controls: an analysis of SLE subgroups
    Gustafsson, J.
    Jensen-Urstad, K.
    Herlitz-Lindberg, M.
    Moller, S.
    Pettersson, S.
    Gunnarsson, I.
    Larsson, A.
    Svenungsson, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 7 - 8
  • [27] EXPRESSION OF MACROPHAGE PROCOAGULANT ACTIVITY (MPCA) IN MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    COLE, EH
    LEVY, GA
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 270 - 270
  • [28] Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity
    Bijl, M
    Horst, G
    Limburg, PC
    Kallenberg, CGM
    LUPUS, 2001, 10 (12) : 866 - 872
  • [29] Cytokine expression in the heart in experimental systemic lupus erythematosus (SLE).
    Tomita, M
    Dragoman, M
    Zhao, J
    Conran, PB
    Santoro, TJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 239A - 239A
  • [30] GENE EXPRESSION SIGNATURES AND PATHWAYS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A META-ANALYSIS STUDY.
    Amur, S. G.
    Mummaneni, P.
    Arasappan, D.
    Tong, W.
    Siegel, J.
    Men, A.
    Nallani, S.
    Dawisha, S.
    Frueh, F.
    Burckart, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S76 - S76
12345